KERYX ALERT: Rosen Law Firm Reminds Keryx Biopharmaceuticals Inc. Investors of Important October 3 Deadline in Class Action NEW YORK, Sept. 16, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Keryx Biopharmaceuticals, Inc. securities (NASDAQ:KERX) from February 25, 2016...

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Keryx Biopharmaceuticals Inc. - KERX NEW YORK, Aug. 31, 2016 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Keryx Biopharmaceuticals,...